Receptor | β3GnT2+/+ | β3GnT2−/− | % Change | p value |
---|
M72 (mOR171-3) | 8,162 +/− 1,062 | 8,008 +/− 1,668 | −3.0 +/− 12.1 | 0.88 |
olfr15 (mOR256-17) | 96,389 +/− 15,250 | 148,170 +/− 14,500 | +59.0 +/− 19.8 | 0.038 |
OR37 (mOR262-14) | 7,579 +/− 521 | 7,073 +/− 1,424 | −8.5 +/− 12.5 | 0.65 |
olfr43 (mOR125-1) | 27,896 +/− 3,550 | 38,339 +/− 3,610 | +38.8 +/− 6.2 | 0.004 |
olfr1370(mOR256-14) | 15,957 +/− 1,833 | 22,161 +/− 2,183 | +39.8 +/− 8.77 | 0.04 |
P2 (mOR263-5) | 25,377 +/− 1,772 | 5,396 +/− 535 | −78.7 +/− 1.7 | 0.001 |
- To analyze any differences within a slide series, In situ experiments were done using the same probe on two slides from a WT series and two from a null series. These slides were found to have less than 3% differences in receptor counts for either genotype. Thus, the total amount of receptors for each probe is an extrapolation from counts made on approximately 5% of the tissue. Statistics are done with a two-Way ANOVA to account for any variability, which may occur between each In situ experiment.